Generate a tailored SOP for Dr. Andrew Willeford. Improve your application with a focused, well-structured draft.
Andrew Willeford’s research focuses on strategies to improve medication implementation for cardiomyopathies and heart failure, particularly those with reduced ejection fraction and hypertrophic cardiomyopathy. His current research includes evaluating clinical outcomes of a pharmacist-led virtual titration clinic for patients with heart failure, which involves creating best-practice models for the utilization of cardiac myosin inhibitors in the treatment of obstructive hypertrophic cardiomyopathy. Willeford has a strong academic background with a Doctorate in Philosophy in Biomedical Sciences and a Doctorate in Pharmacy, both from the University of California, San Diego. He completed his residencies in Acute Care Pharmacy and Cardiology Pharmacy, further strengthening his expertise in these areas. Willeford has also received several prestigious awards, including the Roland K. Robins Outstanding Thesis Award from UC San Diego and the Renee Holder Literature Award from the Society of Pain and Palliative Care Pharmacists. His teaching roles include chairing pharmacotherapy courses and developing clinical rotation programs for pharmacy residents and students.
Administered by the Scripps Institution of Oceanography. Curricular groups include Climate-Ocean-Atmosphere (COAP), Geosciences (GEO), and Ocean Biosciences (OBP).